bioRxivImmunologyPreprint
Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity
M. Hirota, M. Tamai, S. Yukawa, N. Taira, M. M. Matthews, T. Toma, Y. Seto, M. Yoshida, S. Toguchi, M. Miyagi, T. Mori, H. Tomori, O. Tamai, M. Kina, E. Sakihara, C. Yamashiro, M. Miyagi, K. Tamaki, M. Wolf, M. K. Collins, H. Kitano, H. Ishikawa
Abstract
COVID-19 mRNA vaccines induce protective adaptive immunity against SARS-CoV-2 in most individuals, but there is wide variation in levels of vaccine-induced antibody and T-cell responses. However, factors associated with this inter-individual variation remain unclear. Here, using a systems biology approach based on multi-omics analyses of human blood and stool samples, we find that baseline expression of AP-1 transcription factors, FOS and ATF3, is inversely correlated with BNT162b2 mRNA vaccine-induced T-cell responses. FOS expression is associated with transcription modules related to baseline immunity, but it is negatively associated with those related to T-cell activation upon BNT162b2 mRNA stimulation. Interestingly, the gut microbial fucose/rhamnose degradation pathway is positively correlated with FOS and ATF3 expression and inversely correlated with BNT162b2-induced T-cell responses. Taken together, these results demonstrate that baseline expression of AP-1 genes, which is associated with the gut microbial fucose/rhamnose degradation pathway, is a key negative correlate of BNT162b2-induced T-cell responses.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses
Feargal J. Ryan, Todd S. Norton, … David John Lynn·medRxiv·Sep 22, 2022
- Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
P. Kaplonek, D. Cizmeci, … G. Alter·bioRxiv·Aug 31, 2021
- Comparative multi-OMICS single-cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action
Y. Singh, A. Schulze-Selting, … O. Riess·bioRxiv·Sep 12, 2022
- Pre-existing immunity modulates responses to mRNA boosters
T. Dangi, S. Sanchez, … P. Penaloza-MacMaster·bioRxiv·Jun 27, 2022
- The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylatedIgG1 in naive but not antigen-experienced vaccinees
J. Van Coillie, T. Pongracz, … Fatebenefratelli-Sacco Infectious Diseases Physic·bioRxiv·Feb 14, 2022
- Dose-dependent interferon programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination
Giray Naim Eryilmaz, Yilmaz Yucehan Yazici, … Duygu Ucar·bioRxiv·Aug 15, 2025